Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.naperol.com | |
Market Cap | 758.63 Cr. | |
Enterprise Value(EV) | 851.02 Cr. | 2022-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 9.45 | Trailing Twelve Months Ending 2022-03 |
Price-Earning Ratio (PE) | 139.71 | Trailing Twelve Months Ending 2022-03 |
Industry PE | 28.79 | Trailing Twelve Months Ending 2022-03 |
Book Value / Share | 1,584.48 | Trailing Twelve Months Ending 2022-03 |
Price to Book Value | 0.83 | Calculated using Price: 1,320.05 |
Dividend Yield | 0.38 | Period Ending 2021-03 |
No. of Shares Subscribed | 0.57 Cr. | 5,747,000 Shares |
FaceValue | 10 | |
Company Profile | ||
National Peroxide (NPL) was incorporated on March 16, 1954. NPL a pioneer in India for peroxygen chemicals and is the largest manufacturer of hydrogen peroxide in India, with an installed capacity of 49,000 MTPA on 50% w/w. basis. It's fully integrated manufacturing site for hydrogen peroxide is located at Kalyan in Maharashtra. The registered office of the company is located at Neville House, J N Heredia Marg, Ballard Estate Mumbai 400001. The company is engaged in the manufacturers of chemicals hydrogen peroxide and sodium perborate. |
1 Day |
|
-0.60% |
1 Week |
|
+5.99% |
1 Month |
|
-8.80% |
3 Month |
|
-22.45% |
6 Month |
|
-30.06% |
1 Year |
|
-45.10% |
2 Year |
|
-35.45% |
5 Year |
|
+1.43% |
10 Year |
|
+251.26% |
9 years | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | |
Return on Equity (%) | 24.31 | 20.51 | 3.16 | 8.45 | 8.00 | 10.90 | 14.04 | 1.81 | 2.27 | |
Return on Capital Employed (%) | 36.35 | 30.38 | 8.63 | 12.81 | 11.92 | 16.67 | 20.86 | 2.91 | 2.32 | |
Return on Assets (%) | 16.16 | 15.10 | 1.86 | 4.47 | 6.40 | 10.09 | 12.63 | 1.39 | 1.58 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03* Rs. Cr. |
Shh. Funds | 180 | 210 | 212 | 224 | 742 | 1,017 | 1,174 | 802 | 1,067 | 911 | |
Non Curr. Liab. | 18 | 19 | 138 | 127 | 27 | 37 | 110 | 216 | 216 | 49 | |
Curr. Liab. | 41 | 62 | 76 | 49 | 38 | 39 | 59 | 217 | 160 | 108 | |
Minority Int. | |||||||||||
Equity & Liab. | 238 | 291 | 426 | 400 | 807 | 1,093 | 1,342 | 1,235 | 1,443 | 1,068 | |
Non Curr. Assets | 125 | 176 | 283 | 279 | 678 | 883 | 1,010 | 1,045 | 1,278 | 943 | |
Curr. Assets | 113 | 115 | 143 | 121 | 129 | 210 | 333 | 189 | 165 | 125 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 238 | 291 | 426 | 400 | 807 | 1,093 | 1,342 | 1,235 | 1,443 | 1,068 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. TTM |
Net Sales | 213 | 236 | 197 | 234 | 233 | 306 | 402 | 191 | 215 | 226 | |
Other Income | 5 | 6 | 6 | 8 | 6 | 10 | 19 | 18 | 13 | 10 | |
Total Income | 218 | 242 | 203 | 242 | 239 | 316 | 421 | 209 | 228 | 236 | |
Total Expenditure | -146 | -174 | -174 | -198 | -163 | -161 | -175 | -166 | -170 | -209 | |
PBIDT | 72 | 68 | 29 | 44 | 77 | 156 | 246 | 44 | 58 | 27 | |
Interest | 0 | 0 | -5 | -5 | -2 | -1 | -1 | -3 | -13 | -9 | |
Depreciation | -11 | -10 | -7 | -9 | -9 | -9 | -9 | -11 | -18 | -17 | |
Taxation | -21 | -20 | -10 | -11 | -19 | -51 | -82 | -12 | 9 | -3 | |
Exceptional Items | 1 | -1 | -8 | 1 | -15 | 7 | |||||
PAT | 40 | 40 | 7 | 18 | 39 | 96 | 154 | 18 | 21 | 5 | |
Minority Interest | |||||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 40 | 40 | 7 | 18 | 39 | 96 | 154 | 18 | 21 | 5 | |
Adjusted EPS | 70 | 70 | 12 | 32 | 67 | 167 | 268 | 31 | 37 | 9 |
Particulars | 10 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
Cash Fr. Operatn. | 47 | 42 | 29 | 22 | 22 | 60 | 95 | 148 | 16 | 61 | |
Cash Fr. Inv. | -35 | -30 | -22 | -75 | 30 | -33 | -56 | -175 | -39 | -7 | |
Cash Fr. Finan. | -12 | -13 | -7 | 54 | -51 | -28 | -35 | 35 | 14 | -49 | |
Net Change | 0 | -1 | 1 | 0 | -1 | 3 | 8 | -9 | 5 | ||
Cash & Cash Eqvt | 1 | 0 | 0 | 1 | 1 | 0 | 3 | 11 | 2 | 7 |
Tue, 21 Jun 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
Thu, 09 Jun 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication Pursuant to Regulation 30 and 47 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing herewith copy of the newspaper clippings published in the Business Standard (Mumbai) and Mumbai Lakshadeep on June 9 2022 regarding Notice sent to Shareholders for Transfer of Equity Shares of the Company to the DEMAT Account of Investor Education and Protection Fund (IEPF) Authority pursuant to the provisions of the IEPF Authority (Accounting Audit Transfer and Refund) Rules 2016 as amended from time to time. |
Mon, 06 Jun 2022
Disclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations 2015) National Peroxide Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting under Regulation 44(3) of SEBI (LODR) Regulations 2015. Kindly Click here |
Mon, 27 Jun 2022 |
|
|
|
|
|